Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 May 10;12(3):e003989.
doi: 10.1136/bmjdrc-2023-003989.

Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies

Affiliations
Multicenter Study

Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies

Anders L Carlson et al. BMJ Open Diabetes Res Care. .

Abstract

Introduction: To characterize glucose levels during uncomplicated pregnancies, defined as pregnancy with a hemoglobin A1c <5.7% (<39 mmol/mol) in early pregnancy, and without a large-for-gestational-age birth, hypertensive disorders of pregnancy, or gestational diabetes mellitus (ie, abnormal oral glucose tolerance test).

Research design and methods: Two sites enrolled 937 pregnant individuals aged 18 years and older prior to reaching 17 gestational weeks; 413 had an uncomplicated pregnancy (mean±SD body mass index (BMI) of 25.3±5.0 kg/m2) and wore Dexcom G6 continuous glucose monitoring (CGM) devices throughout the observed gestational period. Mealtimes were voluntarily recorded. Glycemic levels during gestation were characterized using CGM-measured glycemic metrics.

Results: Participants wore CGM for a median of 123 days each. Glucose levels were nearly stable throughout all three trimesters in uncomplicated pregnancies. Overall mean±SD glucose during gestation was 98±7 mg/dL (5.4±0.4 mmol/L), median per cent time 63-120 mg/dL (3.5-6.7 mmol/L) was 86% (IQR: 82-89%), median per cent time <63 mg/dL (3.5 mmol/L) was 1.8%, median per cent time >120 mg/dL (6.7 mmol/L) was 11%, and median per cent time >140 mg/dL (7.8 mmol/L) was 2.5%. Mean post-prandial peak glucose was 126±22 mg/dL (7.0±1.2 mmol/L), and mean post-prandial glycemic excursion was 36±22 mg/dL (2.0±1.2 mmol/L). Higher mean glucose levels were low to moderately associated with pregnant individuals with higher BMIs (103±6 mg/dL (5.7±0.3 mmol/L) for BMI ≥30.0 kg/m2 vs 96±7 mg/dL (5.3±0.4 mmol/L) for BMI 18.5-<25 kg/m2, r=0.35).

Conclusions: Mean glucose levels and time 63-120 mg/dL (3.5-6.7 mmol/L) remained nearly stable throughout pregnancy and values above 140 mg/dL (7.8 mmol/L) were rare. Mean glucose levels in pregnancy trend higher as BMI increases into the overweight/obesity range. The glycemic metrics reported during uncomplicated pregnancies represent treatment targets for pregnant individuals.

Keywords: Pregnancy; Reproductive Health; Research.

PubMed Disclaimer

Conflict of interest statement

Competing interests: ALC reports no personal financial disclosures but reports that his institution has received funding on his behalf as follows: research support from Medtronic, Tandem, Insulet, Abbott, Dexcom, Eli Lilly, NovoNordisk, Sanofi and UnitedHealth Group and consultancy fees from Mannkind and NovoNordisk. RWB reports no personal financial disclosures but reports that his institution has received funding on his behalf as follows: grant funding and study supplies from Dexcom. RMB has received research support, has acted as a consultant, or has been on the scientific advisory board for Abbott Diabetes Care, Ascensia, Bigfoot Biomedical, CeQur, Dexcom, Eli Lilly, Embecta, Hygieia, Insulet, Medtronic, Novo Nordisk, Onduo, Roche Diabetes Care, Tandem Diabetes Care, Sanofi, UnitedHealthcare, Vertex Pharmaceuticals and Zealand Pharma. RMB’s employer, non-profit HealthPartners Institute, contracts for his services and he receives no personal income for any of these activities. CD reports advisory work for Dexcom for GDM patient-facing materials and system implementation.

Figures

Figure 1
Figure 1
Distribution of CGM-measured glucose levels throughout uncomplicated pregnancies. Envelope plots of the per cent of CGM values within each glucose level interval for each participant during (A) the entire observed gestational period (N=413) and (C) each trimester (N=118, 413, and 355 in the first, second, and third trimester, respectively). Tracings of participant-level mean glucose levels by the hour of the day during (B) the entire observed gestational period and (D) each trimester. Solid dots and lines represent medians, and open circles represent means. Shaded bands represent the IQR (ie, 25th–75th percentiles). The first, second, and third trimesters are represented by the colors blue, red, and green, respectively. CGM, continuous glucose monitoring.

References

    1. Sweeting A, Wong J, Murphy HR, et al. . A clinical update on gestational diabetes mellitus. Endocr Rev 2022;43:763–93. 10.1210/endrev/bnac003 - DOI - PMC - PubMed
    1. Gestational diabetes mellitus [article online]. 2018. Available: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articl... [Accessed 21 Jul 2023].
    1. Hughes RCE, Moore MP, Gullam JE, et al. . An early pregnancy HbA1c ≥5.9% (41 mmol/Mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care 2014;37:2953–9. 10.2337/dc14-1312 - DOI - PubMed
    1. Immanuel J, Simmons D, Desoye G, et al. . Performance of early pregnancy HbA(1c) for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women. Diabetes Res Clin Pract 2020;168:108378. 10.1016/j.diabres.2020.108378 - DOI - PubMed
    1. Sweeting AN, Ross GP, Hyett J, et al. . Baseline HbA1c to identify high-risk gestational diabetes: utility in early vs standard gestational diabetes. J Clin Endocrinol Metab 2017;102:150–6. 10.1210/jc.2016-2951 - DOI - PubMed

Publication types